222 related articles for article (PubMed ID: 33239505)
1. Genomic Profiling of Low-grade Intramedullary Cartilage Tumors Can Distinguish Enchondroma From Chondrosarcoma.
Joseph NM; McGill KC; Horvai AE
Am J Surg Pathol; 2021 Jun; 45(6):812-819. PubMed ID: 33239505
[TBL] [Abstract][Full Text] [Related]
2. Targeted Next-Generation Sequencing Identifies Molecular and Genetic Events in Dedifferentiated Chondrosarcoma.
Lucas CG; Grenert JP; Horvai A
Arch Pathol Lab Med; 2021 Aug; 145(8):1009-1017. PubMed ID: 33147331
[TBL] [Abstract][Full Text] [Related]
3. Genomic Profiling Identifies Association of
Zhu GG; Nafa K; Agaram N; Zehir A; Benayed R; Sadowska J; Borsu L; Kelly C; Tap WD; Fabbri N; Athanasian E; Boland PJ; Healey JH; Berger MF; Ladanyi M; Hameed M
Clin Cancer Res; 2020 Jan; 26(2):419-427. PubMed ID: 31615936
[TBL] [Abstract][Full Text] [Related]
4. Frequent mutation of the major cartilage collagen gene COL2A1 in chondrosarcoma.
Tarpey PS; Behjati S; Cooke SL; Van Loo P; Wedge DC; Pillay N; Marshall J; O'Meara S; Davies H; Nik-Zainal S; Beare D; Butler A; Gamble J; Hardy C; Hinton J; Jia MM; Jayakumar A; Jones D; Latimer C; Maddison M; Martin S; McLaren S; Menzies A; Mudie L; Raine K; Teague JW; Tubio JM; Halai D; Tirabosco R; Amary F; Campbell PJ; Stratton MR; Flanagan AM; Futreal PA
Nat Genet; 2013 Aug; 45(8):923-6. PubMed ID: 23770606
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic utility of IDH1/2 mutations to distinguish dedifferentiated chondrosarcoma from undifferentiated pleomorphic sarcoma of bone.
Chen S; Fritchie K; Wei S; Ali N; Curless K; Shen T; Brini AT; Latif F; Sumathi V; Siegal GP; Cheng L
Hum Pathol; 2017 Jul; 65():239-246. PubMed ID: 28552826
[TBL] [Abstract][Full Text] [Related]
6. Distinct IDH1/2-associated Methylation Profile and Enrichment of
Dermawan JKT; Nafa K; Mohanty A; Xu Y; Rijo I; Casanova J; Villafania L; Benhamida J; Kelly CM; Tap WD; Boland PJ; Fabbri N; Healey JH; Ladanyi M; Lu C; Hameed M
Cancer Res Commun; 2023 Mar; 3(3):431-443. PubMed ID: 36926116
[TBL] [Abstract][Full Text] [Related]
7. Distinct Roles of Glutamine Metabolism in Benign and Malignant Cartilage Tumors With IDH Mutations.
Zhang H; Puviindran V; Nadesan P; Ding X; Shen L; Tang YJ; Tsushima H; Yahara Y; Ban GI; Zhang GF; Karner CM; Alman BA
J Bone Miner Res; 2022 May; 37(5):983-996. PubMed ID: 35220602
[TBL] [Abstract][Full Text] [Related]
8. MR differentiation of low-grade chondrosarcoma from enchondroma.
Choi BB; Jee WH; Sunwoo HJ; Cho JH; Kim JY; Chun KA; Hong SJ; Chung HW; Sung MS; Lee YS; Chung YG
Clin Imaging; 2013; 37(3):542-7. PubMed ID: 23041161
[TBL] [Abstract][Full Text] [Related]
9. Genomic profiling of chondrosarcoma: chromosomal patterns in central and peripheral tumors.
Hallor KH; Staaf J; Bovée JV; Hogendoorn PC; Cleton-Jansen AM; Knuutila S; Savola S; Niini T; Brosjö O; Bauer HC; Vult von Steyern F; Jonsson K; Skorpil M; Mandahl N; Mertens F
Clin Cancer Res; 2009 Apr; 15(8):2685-94. PubMed ID: 19336518
[TBL] [Abstract][Full Text] [Related]
10. Cartilage-forming tumors.
Qasem SA; DeYoung BR
Semin Diagn Pathol; 2014 Jan; 31(1):10-20. PubMed ID: 24680178
[TBL] [Abstract][Full Text] [Related]
11. Integrating Morphology and Genetics in the Diagnosis of Cartilage Tumors.
de Andrea CE; San-Julian M; Bovée JVMG
Surg Pathol Clin; 2017 Sep; 10(3):537-552. PubMed ID: 28797501
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of A disintegrin and metalloproteinase 28 is correlated with high histologic grade in conventional chondrosarcoma.
Matsuura S; Oda Y; Matono H; Izumi T; Yamamoto H; Tamiya S; Iwamoto Y; Tsuneyoshi M
Hum Pathol; 2010 Mar; 41(3):343-51. PubMed ID: 19896699
[TBL] [Abstract][Full Text] [Related]
13. Molecular analysis of the INK4A/INK4A-ARF gene locus in conventional (central) chondrosarcomas and enchondromas: indication of an important gene for tumour progression.
van Beerendonk HM; Rozeman LB; Taminiau AH; Sciot R; Bovée JV; Cleton-Jansen AM; Hogendoorn PC
J Pathol; 2004 Mar; 202(3):359-66. PubMed ID: 14991902
[TBL] [Abstract][Full Text] [Related]
14. Use of MicroRNA biomarkers to distinguish enchondroma from low-grade chondrosarcoma.
Zhang L; Yang M; Mayer T; Johnstone B; Les C; Frisch N; Parsons T; Mi QS; Gibson G
Connect Tissue Res; 2017 Mar; 58(2):155-161. PubMed ID: 27267924
[TBL] [Abstract][Full Text] [Related]
15. Chondroid Tumors as Incidental Findings and Differential Diagnosis between Enchondromas and Low-grade Chondrosarcomas.
Afonso PD; Isaac A; Villagrán JM
Semin Musculoskelet Radiol; 2019 Feb; 23(1):3-18. PubMed ID: 30699449
[TBL] [Abstract][Full Text] [Related]
16. Isocitrate dehydrogenase 1 mutations (IDH1) and p16/CDKN2A copy number change in conventional chondrosarcomas.
Amary MF; Ye H; Forbes G; Damato S; Maggiani F; Pollock R; Tirabosco R; Flanagan AM
Virchows Arch; 2015 Feb; 466(2):217-22. PubMed ID: 25432631
[TBL] [Abstract][Full Text] [Related]
17. Differentiating clinical and radiographic features of enchondroma and secondary chondrosarcoma in the foot.
Gajewski DA; Burnette JB; Murphey MD; Temple HT
Foot Ankle Int; 2006 Apr; 27(4):240-4. PubMed ID: 16624212
[TBL] [Abstract][Full Text] [Related]
18. Radiographic differentiation of enchondroma from low-grade chondrosarcoma in the fibula.
Kendell SD; Collins MS; Adkins MC; Sundaram M; Unni KK
Skeletal Radiol; 2004 Aug; 33(8):458-66. PubMed ID: 15221215
[TBL] [Abstract][Full Text] [Related]
19. Evidence of an association between 6q13-21 chromosome aberrations and locally aggressive behavior in patients with cartilage tumors.
Sawyer JR; Swanson CM; Lukacs JL; Nicholas RW; North PE; Thomas JR
Cancer; 1998 Feb; 82(3):474-83. PubMed ID: 9452264
[TBL] [Abstract][Full Text] [Related]
20. Molecular distinction of chondrosarcoma from chondroblastic osteosarcoma through IDH1/2 mutations.
Kerr DA; Lopez HU; Deshpande V; Hornicek FJ; Duan Z; Zhang Y; Rosenberg AE; Borger DR; Nielsen GP
Am J Surg Pathol; 2013 Jun; 37(6):787-95. PubMed ID: 23598960
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
